DOMH Projected Dividend Yield
Dominari Holdings Inc ( NASDAQ : DOMH )Dominari Holdings is a biotechnology company seeking to develop small-molecule anti-cancer therapeutics. Co. owns the rights to patented technology from universities and researchers and it is in the process of developing therapeutic drugs through partnerships with educational institutions. Co.'s pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Co.'s AML and ALL compounds are targeted therapeutics designed to overcome various resistance mechanisms observed with the existing standard of care. DHA-dFdC, Co.'s pancreatic drug, is a compound poised to become the chemotherapy treatment for pancreatic cancer. 20 YEAR PERFORMANCE RESULTS |
DOMH Dividend History Detail DOMH Dividend News DOMH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |